BioSpace News Archive

In Pew Survey, Black Americans Express Concern About Potential for Research Misconduct

55% of respondents describe misconduct by medical research scientists as being a moderate or a very big problem.

April 8, 2022
·
3 min read
·
Hayley Shasteen
Drug Development

Clinical Catch-Up: COVID-19, AAN, ACC

It was a very busy week for clinical trial news, in part because of presentations coming out of the American Academy of Neurology (AAN) meeting. Here’s a look.

April 8, 2022
·
12 min read
·
Mark Terry
Policy

COVID-19 By the Numbers: Nearly a Half Billion Global Cases and Counting

COVID-19 has killed more than six million people worldwide and almost one million in the U.S. And the pandemic isn’t over yet. Read on for that and more updates about COVID-19.

April 8, 2022
·
4 min read
·
Mark Terry
Agoraphobia Treatment Market: Rise the agoraphobia and related psychological fears among people to drive the market

Agoraphobia can be defined as an anxiety disorder, in which people tend to avoid places or situations where they feel trapped. The fear can be related to using public transportation, being in enclosed or open spaces, or being in the crowd.

April 8, 2022
·
5 min read
Magnetic Beads Market Growth, Trends, Drivers, and Key Players in the Industry – Global Analysis Report

The magnetic beads market has been estimated to grow at a noticeable speed in the upcoming years.

April 8, 2022
·
5 min read
Tiamulin Drugs Market: North America to Capture Major Share of Global Market

Tiamulin is a pleuromutilin antibiotic drug that is used in veterinary medicine, particularly for pigs and poultry. It is also used for bacterial infection in animals. It is a semisynthetic derivative of the diterpene antibiotic pleuromutilin.

April 8, 2022
·
5 min read
Business

Evotec Achieves Programme Designation in Neuroscience Collaboration with Bristol Myers Squibb

Evotec SE announced that the Company has reached another programme designation within its neuroscience collaboration with Bristol Myers Squibb triggering a payment of US$ 16 m to Evotec.

April 8, 2022
·
6 min read
AGC to Expand Synthetic Pharmaceutical Production Base in Spain

AGC Inc. (hereinafter “AGC”), a Tokyo -based world-leading manufacturer of glass, chemicals, high-tech materials, has decided to expand the facilities of AGC Pharma Chemicals Europe S.L.U. (hereinafter “APCE”), an AGC subsidiary in Spain engaged in the synthetic pharmaceutical (*1) CDMO (*2) business.

April 8, 2022
·
2 min read
FDA

Amphastar Receives FDA Approval for Ganirelix Acetate Injection

Amphastar Pharmaceuticals, Inc., announced that the U.S. Food and Drug Administration has approved the Company’s Abbreviated New Drug Application for Ganirelix Acetate Injection, 250mg/0.5mL in a prefilled syringe.

April 8, 2022
·
4 min read
Biotech Bay

TPX-100: OrthoTrophix Presents New Data Suggesting Joint Bone Shape as a Possible Surrogate Marker for Virtual Joint Replacement in Knee Osteoarthritis

OrthoTrophix, Inc., a privately held biopharmaceutical company, announced that the Company and its collaborators present clinical data strongly supporting joint bone shape change as part of a surrogate marker predictive of joint replacement in knee osteoarthritis patients.

April 8, 2022
·
3 min read